As of 2015, the 340B Drug Pricing Program mandates that drug manufacturers provide eligible health care organizations and covered entities with outpatient drugs at deeply discounted prices, according to the U.S. Department of Health and Human Services, Health Resources and Services Administration. Eligible organizations and covered entities must register, enroll in and comply with program requirements to participate in the 340B program. After enrollment, covered entities receive 340B identification numbers for vendor verification before organizations can purchase discounted drugs.
Organizations eligible for the 340B Drug Pricing Program can submit new registrations quarterly, from January 1 through 15, April 1 through 15, July 1 through 15, and October 1 through 15, notes the U.S. Department of Health and Human Services, Health Resources and Services Administration. Organizations using the program are able to assist more patients with a broader range of services by expanding the reach of federal government resources. HRSA-supported health centers, state-run AIDS drug assistance programs, Ryan White clinics, children's hospitals and Medicare/Medicaid disproportionate share hospitals are among the eligible health care organizations and covered entities participating in the 340B program.
The drug pricing program provides discounts for outpatient prescription drugs and insulin that the U.S. Food and Drug Administration has approved; over-the-counter drugs for which doctors have written prescriptions; and biological products (excluding vaccines) that patients can obtain only by prescription, explains the U.S. Department of Health and Human Services, Health Resources and Services Administration.